1252611-25-8
Chemical Structure
Olanzapine-d15
Synonym(s): LY170053-d15
- CAS No.: 1252611-25-8
- Formula:C17H5D15N4S
- Molecular Weight:327.52
InChIKey: KVWDHTXUZHCGIO-DFCMNMIGSA-N
SMILES: CC1=CC2=C(S1)NC3=C([2H])C([2H])=C([2H])C([2H])=C3N=C2N4C([2H])([2H])C([2H])([2H])N(C([2H])([2H])C4([2H])[2H])C([2H])([2H])[2H]
Biological Activity: Olanzapine-d15 (LY170053-d15) is the deuterium labeled Olanzapine (HY-14541). Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki = 7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki = 11 to 31 nM), muscarinic M1-5 (Ki = 1.9-25 nM), and adrenergic α1 receptor (Ki = 19 nM). Olanzapine is an atypical antipsychotic.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Olanzapine-d15 | Olanzapine-d15 (LY170053-d15) is the deuterium labeled Olanzapine (HY-14541). Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki = 7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki = 11 to 31 nM), muscarinic M1-5 (Ki = 1.9-25 nM), and adrenergic α1 receptor (Ki = 19 nM). Olanzapine is an atypical antipsychotic. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine (Standard) | 99.98% | Olanzapine (Standard) is the analytical standard of Olanzapine. This product is intended for research and analytical applications. Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine is an atypical antipsychotic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine-d4 | Olanzapine-d4 (LY170053-d4) is deuterium-labeled Olanzapine (HY-14541). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine-d8 | Olanzapine-d8 is a deuterated labeled Olanzapine. Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine is an atypical antipsychotic. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine-d3 | 98.57% | Olanzapine-d3 (LY170053-d3) is the deuterium labeled Olanzapine. Olanzapine is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptors (Ki=19 nM). Olanzapine is an atypical antipsychotic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olanzapine | 99.96% | Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine is an atypical antipsychotic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
